Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosisYongqiang Li, Lixia Wang|Experimental and Therapeutic Medicine|2017Cited by 19